Easton Pharmaceutica Gross Profit vs. Book Value Per Share
| EAPH Stock | USD 0.0001 0.00 0.00% |
Gross Profit | First Reported 2010-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 64.7 K |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.14 | 0.15 |
|
|
For Easton Pharmaceutica profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Easton Pharmaceutica to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Easton Pharmaceutica utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Easton Pharmaceutica's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Easton Pharmaceutica over time as well as its relative position and ranking within its peers.
Easton |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Easton Pharmaceutica. If investors know Easton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Easton Pharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.001 | Return On Assets (0.01) | Return On Equity (0.03) |
The market value of Easton Pharmaceutica is measured differently than its book value, which is the value of Easton that is recorded on the company's balance sheet. Investors also form their own opinion of Easton Pharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is Easton Pharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Easton Pharmaceutica's market value can be influenced by many factors that don't directly affect Easton Pharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Easton Pharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Easton Pharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Easton Pharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Easton Pharmaceutica Book Value Per Share vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Easton Pharmaceutica's current stock value. Our valuation model uses many indicators to compare Easton Pharmaceutica value to that of its competitors to determine the firm's financial worth. Easton Pharmaceutica is one of the top stocks in gross profit category among its peers. It also is one of the top stocks in book value per share category among its peers . The ratio of Gross Profit to Book Value Per Share for Easton Pharmaceutica is about 40,279,000 . As of now, Easton Pharmaceutica's Gross Profit is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Easton Pharmaceutica's earnings, one of the primary drivers of an investment's value.Easton Book Value Per Share vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Easton Pharmaceutica |
| = | 201.4 K |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Easton Pharmaceutica |
| = | 0.01 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Easton Book Value Per Share Comparison
Easton Pharmaceutica is currently under evaluation in book value per share category among its peers.
Easton Pharmaceutica Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Easton Pharmaceutica, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Easton Pharmaceutica will eventually generate negative long term returns. The profitability progress is the general direction of Easton Pharmaceutica's change in net profit over the period of time. It can combine multiple indicators of Easton Pharmaceutica, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -216.8 K | -227.7 K | |
| Net Loss | -216.8 K | -227.7 K | |
| Income Before Tax | -216.8 K | -227.7 K | |
| Total Other Income Expense Net | -40.5 K | -42.5 K | |
| Net Loss | -216.8 K | -227.7 K | |
| Net Loss | -216.8 K | -227.7 K | |
| Change To Netincome | -308 K | -292.6 K | |
| Income Quality | (1.82) | (1.73) | |
| Net Income Per E B T | 1.15 | 1.11 |
Easton Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Easton Pharmaceutica. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Easton Pharmaceutica position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Easton Pharmaceutica's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Easton Pharmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Use Investing Themes to Complement your Easton Pharmaceutica position
In addition to having Easton Pharmaceutica in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Shipbuilding Railroad Equipment Thematic Idea Now
Shipbuilding Railroad Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. For more detail on how to invest in Easton Stock please use our How to Invest in Easton Pharmaceutica guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
To fully project Easton Pharmaceutica's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Easton Pharmaceutica at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Easton Pharmaceutica's income statement, its balance sheet, and the statement of cash flows.